249 related articles for article (PubMed ID: 15293904)
1. [Varicella-zoster virus seroprevalence in children between 0-15 years old].
Savaş S; Dallar Y; Arikan I; Onde U
Mikrobiyol Bul; 2004; 38(1-2):69-75. PubMed ID: 15293904
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of varicella-zoster virus in Polish population.
Siennicka J; Trzcińska A; Rosińska M; Litwińska B
Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
Heininger U; Desgrandchamps D; Schaad UB
Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of mumps, varicella and rubella antibodies in children 1-16 years of age in eastern Turkey.
Gürgöze MK; Yilmaz E; Gödekmerdan A; Akça Z; Doğan Y; Akarsu S; Aygün AD
Turk J Pediatr; 2006; 48(3):185-8. PubMed ID: 17172059
[TBL] [Abstract][Full Text] [Related]
6. Varicella seroprevalence in Turkish population in Cyprus.
Kurugol Z; Koturoglu G; Aksit S; Ozacar T
Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
[TBL] [Abstract][Full Text] [Related]
7. Varicella zoster seroprevalence in children less than 5 years old.
Ozkan S; Maral I; Ilhan F; Aycan S; Cirak MY; Beyazova U; Aygun R
J Trop Pediatr; 2005 Jun; 51(3):141-4. PubMed ID: 15831668
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of varicella-zoster virus in Korea.
Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
J Med Virol; 2010 Dec; 82(12):2123-6. PubMed ID: 20981803
[TBL] [Abstract][Full Text] [Related]
9. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
[TBL] [Abstract][Full Text] [Related]
10. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
[TBL] [Abstract][Full Text] [Related]
11. Immunity to varicella zoster virus in young Israeli adults.
Avrahami-Heller Y; Cohen D; Orr N; Slepon R; Ashkenazi I; Danon YL
Isr Med Assoc J; 2000 Mar; 2(3):196-9. PubMed ID: 10774265
[TBL] [Abstract][Full Text] [Related]
12. Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.
Chang CK; Tan HF; Tseng HF; Lin CC
Med Mal Infect; 2007 Apr; 37(4):222-8. PubMed ID: 17368781
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiology of varicella-zoster in Pakistan.
Akram DS; Qureshi H; Mahmud A; Khan AA; Kundi Z; Shafi S; N-ur-Rehman ; Olowokure B; Weil J; Bock H; Yazdani I
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):646-9. PubMed ID: 11414405
[TBL] [Abstract][Full Text] [Related]
14. Age related seroprevalence of antibodies to varicella in India.
Lokeshwar MR; Agrawal A; Subbarao SD; Chakraborty MS; Ram Prasad AV; Weil J; Bock HL; Kanwal S; Shah RC; Shah N
Indian Pediatr; 2000 Jul; 37(7):714-9. PubMed ID: 10906803
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
[TBL] [Abstract][Full Text] [Related]
16. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
Koturoglu G; Kurugol Z; Turkoglu E
Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
[TBL] [Abstract][Full Text] [Related]
19. [Investigation on sera prevalence rate of varicella and immunogenicity of varicella vaccine in healthy children].
Zhou T; Wang J; Qiu P
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Oct; 19(5):271-3. PubMed ID: 10322684
[TBL] [Abstract][Full Text] [Related]
20. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
